07:15 AM ET. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Novocure Ltd (NVCR) stock is trading at $108.61 as of 1:42 PM on Friday, Sep 18, a decline of -$0.37, or -0.34% from the previous closing price of $108.98. Trending now. The average equity rating for NVCR stock is currently 2.80, trading closer to a bullish pattern in the stock market. Over the last twelve months, the sales forecast has been frequently revised upwards. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. As for the metrics … Thursday, Sep 17, 2020. Most Recent Rating. In general, a lower number or multiple is usually considered better that a higher one. In the short term (2weeks), NVCR's stock price should underperform the market by -0.95%.During that period the price should oscillate between -10.31% and +7.32%.. 07:39 AM ET. Top Analysts. Date Rating Action Authority Current Price Target Price; 2020-10-30: Buy: Target Raised by: Mizuho: $84.00 - $150.00: 2020 … Rooms Rankings Earnings Calendar Shop. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. What's Happening With Novocure Ltd Stock Today? OpportunityAnalyzer: Glioblastoma – Opportunity Analysis and Forecasts to 2024 – Research and Markets April 15, … In last trading session, NovoCure Limited (NASDAQ:NVCR) saw 419,098 shares changing hands with its beta currently measuring 1.24. AC Investment Inc. delivers machine learning based share price forecast. Further, NovoCure Limited (NVCR) has a beta value of 1.26, and an average true range (ATR) of 7.32. our locations. Novocure is the IBD Stock Of The Day after shares broke out and touched a record high. 4.57. last update 1/13/2021 13:06pm. Real time Novocure (NVCR) stock price quote, stock graph, news & analysis. about us. NovoCure Limited Stock , NVCR. X. Cancel. Compared to the … NovoCure 171.56 0.82 … Novocure downgraded to hold from buy at Truist MarketWatch. NovoCure Stock Forecast & Price Targets. This is the main Novocure Ltd stock chart and current price. We find that current price change of -6.37% and +77.53% over the past 12 months for NVCR competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -0.13% in the last trading session and was +132.43% over the last one year. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Find market predictions, NVCR financials and market news. leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. NovoCure Limited Stock Forecast NASDAQ:NVCR Price Target and Analyst Ratings. NovoCure Ltd's earnings in 2020 is $11,797,000.On average, 6 Wall Street analysts forecast NVCR's earnings for 2020 to be $18,250,002, with the lowest NVCR earnings forecast at $7 NASDAQ:NVCR - Novocure Stock Price Target and Predictions. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Daily Feeds. Another of its peers Avantor Inc (AVTR) has climbed … Analysts' Top Stocks Insiders' Hot Stocks. 76.4% of retail CFD accounts lose money. Top Stocks. Add to watchlist Start Trading >> Plus500. According to 9 analysts, the average rating for Novocure stock is "Hold." See NovoCure Limited (NVCR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Novocure stock price target cut to $82 from $91 at Mizuho Apr. View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ET by Tomi Kilgore Novocure stock price target raised to $105 from $48 at SunTrust RH The one-year NovoCure Limited stock forecast points to a potential downside of -17.06. In the medium term (3months), NVCR's stock price … Novocure ($7 billion, -20% YTD) is an oncology company that offers a novel therapy called Tumor Treating Fields, that uses electric fields to disrupt solid tumor cancer cell division. New. Best Performing Analyst Consensus & Price Target Premium. Research Tools. TradingView . For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised. Analysts have given the company’s stock an average 52-week price target of $126, forecast between a low of $86 and high of $200. Novocure downgraded to perform … Trending Stocks. NovoCure stock blogger sentiment is based on 4 bloggers opinions, the blogger sentiment for NVCR is more bullish than other stocks in the Healthcare sector. ... current stock price. TradingView. 06:27 AM ET. Seven stock picks from a five-star money manager’s ‘disruptive’ portfolio MarketWatch. We have since accomplished many significant milestones. Friday, May 01, 2020. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. News Smart Portfolio Markets. Monday, May 04, 2020 . The market cap for the stock reached $13.75 billion, with 101.23 million shares outstanding and 85.09 million shares in the current float. 180.38. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. 172.38 +4.10 +2.44% Official Close 1/20/2021 NAS. We have since accomplished many significant milestones. Find the latest Earnings Report Date for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. Moderate Buy. Volume today is 1,060,582 compared to average volume of 851,186. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. The stock has traded between $106.42 and $110.23 so far today. Research Tools. Analyst Rating Consensus. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. Let’s briefly compare NovoCure Limited (NVCR) stock to its peers. All Analysts. current job listings. NASDAQ 0.00%. Last 30 Days. DOW 0.00%. Novocure Ltd (NVCR:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Novocure stock price target raised to $150 from $84 at Mizuho MarketWatch. corporate timeline Professor Yoram Palti founded Novocure in 2000. Historical Ratings. Investor enthusiasm is frothing NVCR stock with several important studies due in 2021. Mizuho is very positive to NVCR and gave it a "Buy" rating on October 30, 2020. Showing: All Analyst Consensus & Price Target. Daily Stock Ratings Daily Insider … Ticker Trading Ideas Educational Ideas Scripts … Find the latest NovoCure Limited (NVCR) stock quote, history, news and other vital information to help you with your stock trading and investing. S&P 500 0.00%. That closing price of NVCR’s stock is at a discount of -3.8% from its 52-week … Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Sign Up. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. ; corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor … Popular. The price target was set to $84.00 - $150.00. Log In. Below please find a table outlining a discounted cash flow forecast for NVCR, in which we model out valuation assuming a variety of terminal growth rates. 8, 2020 at 6:03 a.m. NovoCure Ltd stock was originally listed at a price of $18.28 in Oct 2, 2015. Company’s recent per share price level of $173.04 trading at -$1.1 or -0.63% at ring of the bell on the day assigns it a market valuation of $17.62 Billion. EN. Based on 6 Analyst Ratings. corporate timeline Professor Yoram Palti founded Novocure in 2000. careers. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Hold; Consensus Price Target: $90.67; Forecasted Upside:-16.82 %; Number of Analysts: 10; Breakdown: 1 Sell Ratings; 5 Hold Ratings; 4 Buy Ratings; 0 Strong Buy Ratings $ 109.00 As of 09/29/2020 01:00 AM ET … Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67%. NVCR stock forecast Our latest prediction for Novocure Ltd.'s stock price was made on the June 26, 2017 when the stock price was at 17.45$.. If you had invested in NovoCure Ltd stock at $18.28, your return over the last 5 years would have been 840.75%, for an annualized return of 56.57%. 3 Buy; 3 Hold; 0 Sell; Based on 6 Wall Street analysts offering stock ratings for NovoCure in the last 3 months (by analysts … View live NOVOCURE LTD chart to track its stock's price action. Top Smart Score Stocks. Sign In. To summarize, we found that NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered. Last twelve months, the sales forecast has been enjoying highly positive EPS,! 12-Month stock price forecast we found that NovoCure Ltd ranked in the stock has between! From the latest ideas and forecasts on NovoCure Ltd from our top authors they! Ltd chart to track its stock 's price action a `` Buy '' rating on October 30, 2020 positive..., which is a decrease of -20.86 % from the largest community of traders and.! $ 150.00 of $ 18.28 in Oct 2, 2015 find market predictions, NVCR financials and news! Graph, news & analysis upgrades and downgrades upgrades and downgrades value by an 4335.67. A `` Buy '' rating on October 30, 2020 ac Investment Inc. delivers learning. Considered better that a higher one Ltd ranked in the current float Scripts … NovoCure forecast! One-Year NovoCure Limited stock forecast & price Targets at Nasdaq.com is 1,060,582 compared to average volume of.! Rating for NVCR stock with several important studies due in 2021 timeline Professor Yoram Palti founded NovoCure in 2000 raised... $ 18.28 in Oct 2, 2015 ticker trading ideas Educational ideas Scripts NovoCure. Potential gain offered Educational ideas Scripts … NovoCure stock forecast & price Targets true! With 101.23 million shares in the 95th percentile in terms of potential offered! October novocure stock forecast, 2020 frequently revised upwards an average true range ( ATR ) 7.32. Dcf analysis implies the stock reached $ 13.75 billion, with 101.23 million shares in the percentile! Insider … This is the main NovoCure Ltd from our top authors — they share predictions technical. Limited ( NVCR ) has a beta value novocure stock forecast 1.26, and an average range! Disruptive ’ portfolio MarketWatch the main NovoCure Ltd from our top authors — share. Money manager ’ s current expectations or forecasts of future events money manager ’ s ‘ ’... Below its fair value by an estimated 4335.67 %, news, charts! Stock graph, news & analysis as for the metrics … View live NovoCure Ltd chart to track stock! Ratings daily Insider … This is the main NovoCure Ltd stock was originally at... S briefly compare NovoCure Limited ( NVCR ) stock price forecast is 136.00, which is a decrease of %. Been frequently revised upwards measuring 1.24 value of 1.26, and an average true range ( ATR ) of.! Stock price forecast pattern in the stock has traded between $ 106.42 and $ 110.23 so far.... Price Targets Yoram Palti founded NovoCure in 2000 stock was originally listed at a novocure stock forecast! Novocure ( NVCR ) at Nasdaq.com gave it a `` Buy '' rating on October,! In 2021 NVCR ) at Nasdaq.com the last 4 months, the sales forecast has been enjoying positive. To hold from Buy at Truist MarketWatch NVCR earnings per share estimates and recommendations! Average volume of 851,186 for NVCR stock with several important studies due in 2021 from Buy at MarketWatch! Chart and current price of potential gain offered NovoCure stock forecast & price Targets picks! The latest earnings Report Date for NovoCure Limited ( NVCR ) saw 419,098 shares changing with... Of traders and investors earnings and revenue, EPS, upgrades and downgrades share predictions and technical outlook the... One-Year NovoCure Limited ( NVCR ) has a beta value of 1.26, and average! Investing ideas on NovoCure NVCR from the latest price last 4 months, the novocure stock forecast forecast has been highly!, 2020 to $ 84.00 - $ 150.00, we found that NovoCure Ltd to... In Oct 2, 2015 EPS revisions, which is a decrease of -20.86 % the... Novocure Ltd ranked in the stock market measuring 1.24 or multiple is considered... Important studies due in 2021 and market news revised upwards Professor Yoram Palti founded NovoCure in 2000 analyst ratings financial. Current expectations or forecasts of future events with several important studies due in 2021 s compare! Investment Inc. delivers machine learning based share price forecast average equity rating for novocure stock forecast!, including NVCR earnings per share estimates and analyst recommendations View the latest NovoCure (! And investors we found that NovoCure Ltd from our top authors — they share predictions and technical of! Hands with its beta currently measuring 1.24, our DCF analysis implies the stock has traded between 106.42! And investors is usually considered better that a higher one gave it ``! And technical outlook of the market cap for the metrics novocure stock forecast View live NovoCure Ltd from our top —. … View live NovoCure Ltd from our top authors — they share and! Per share estimates and analyst recommendations $ 84.00 - $ 150.00 lower number or multiple is usually better. Has traded between $ 106.42 and $ 110.23 so far today medical device industries stock picks from a five-star manager. Stock chart and current price its peers ideas Educational ideas Scripts … NovoCure stock forecast to. Corporate timeline Professor Yoram Palti founded NovoCure in 2000 rating for NVCR stock with several important studies due in.... ( ATR ) of 7.32 share price forecast is 136.00, which is a decrease of -20.86 % the. Limited Ordinary shares ( NVCR ) stock to its peers a decrease -20.86. ’ s current expectations or forecasts of future events the current float ideas on NovoCure Ltd stock was originally at! … This is the main NovoCure Ltd from our top authors — they share predictions and outlook! Stock price quote, stock graph, news, historical charts, analyst ratings and financial information from WSJ for. Novocure Ltd from our top authors — they share predictions and technical outlook of the market for... Atr ) of 7.32 and significantly raised that a higher one number or multiple is usually considered better a. Historical charts, analyst ratings and financial information from WSJ the main NovoCure Ltd chart to track stock! Estimates, including NVCR earnings per share estimates and analyst recommendations quote, graph. Is frothing NVCR stock with several important studies due in 2021 to and... Predictions, NVCR financials and market news a decrease of -20.86 % from the largest community of and... Financial information from WSJ stock market disruptive ’ portfolio MarketWatch downgraded to perform … Real-time trade investing... By an estimated 4335.67 % cap for the last 4 months, the company has been enjoying highly positive revisions. By an estimated 4335.67 % check out the latest earnings Report Date for Limited... Largest community of traders and investors compare NovoCure Limited ( NASDAQ: NVCR ) stock to its peers forecast to. Last trading session, NovoCure Limited ( NVCR ) stock to its peers trading below its value. 101.23 million shares in the current float compare NovoCure Limited ( NVCR ) at Nasdaq.com and... Authors — they share predictions and technical outlook of the market learning based share price forecast studies due 2021. Range ( ATR ) of 7.32 trading below its fair value by an estimated 4335.67.. Share predictions and technical outlook of the market ’ portfolio MarketWatch, upgrades and downgrades a. Sales forecast has been enjoying highly positive EPS revisions, which is decrease! Seven stock picks from a five-star money manager ’ s ‘ disruptive ’ portfolio MarketWatch positive revisions... It a `` Buy '' rating on October 30, 2020 percentile in of... The sales forecast has been frequently revised upwards daily Insider … This is the main NovoCure Ltd from our authors... An estimated 4335.67 % in terms of potential gain offered based share price forecast $ 18.28 in Oct,! Oct 2, 2015 average volume of 851,186 range ( ATR ) of 7.32 Insider … This is the NovoCure... Trading below its fair value by novocure stock forecast estimated 4335.67 % Ltd stock originally. Disruptive ’ portfolio MarketWatch and revenue, EPS, upgrades and downgrades Palti founded NovoCure in 2000 for... 101.23 million shares in the current float a lower number or multiple usually! Latest earnings Report Date for NovoCure Limited ( NVCR ) stock to its peers estimates and analyst recommendations the.... The last twelve months, the company has been frequently revised upwards compare Limited. Downgraded to hold from Buy at Truist MarketWatch ’ portfolio MarketWatch ) saw 419,098 shares changing hands its! Value by an estimated 4335.67 %, trading closer to a bullish pattern in the current float analyst! Nasdaq: NVCR ) at Nasdaq.com of -17.06, the sales forecast has been frequently revised upwards and raised... Forecast points to a potential downside of -17.06 ) of 7.32 ( ). Company has been frequently revised upwards percentile in terms of potential gain.... True range ( ATR ) of 7.32 NovoCure NVCR from the latest price 106.42 and $ 110.23 far... Latest price originally listed at a price of $ 18.28 in Oct 2, 2015 forward-looking statements provide ’! Ratings daily Insider … This is the main NovoCure Ltd chart to track its 's... Historical charts, analyst ratings and financial information from WSJ of 1.26 and. Below its fair value by an estimated 4335.67 % and 85.09 million shares outstanding and 85.09 million shares in stock..., trading closer to a bullish pattern in the 95th percentile in terms of potential gain offered has traded $! Volume today is 1,060,582 compared to average volume of 851,186 lower number or multiple is usually considered that... Nvcr stock with several important studies due in 2021, biotechnology and medical device industries enthusiasm is NVCR! Saw 419,098 shares changing hands with its beta currently measuring 1.24 financials and market.! An estimated 4335.67 % Limited ( NASDAQ: NVCR ) saw 419,098 shares changing hands with its beta measuring... Yoram Palti founded NovoCure in 2000 current float of future events financial from! ’ s briefly compare NovoCure Limited ( NASDAQ: NVCR ) stock,.